Prescription drug monitoring programs (PDMPs) collect patient-specific prescription information in centralized databases in an effort to reduce the misuse of controlled medicines. This dataset encompasses laws regulating which professions have access to the database and for what purpose, whether practitioners can delegate their access, whether patients can see their own information, and the extent to which access to individually-identified records may be granted for law enforcement purposes.

This is a longitudinal dataset, displaying laws from January 1, 1998 to July 1, 2016.

Prescription drug monitoring programs (PDMPs) collect patient-specific prescription information in centralized databases in an effort to reduce the misuse of controlled substances. This dataset captures the important dates for each state’s PDMP, including the dates of enactment, operation, and user access. These dates were compiled through contact with PDMP administrators from each state program by Brandeis’ PDMP Training and Technical Assistance Center (TTAC). The information is publicly available and is published here in dataset format with the permission of Brandeis’ PDMP TTAC.

According to the 2014 National Survey on Drug Use and Health (NSDUH), 10 million people aged 12 or older reported driving under the influence of illicit drugs. As more states have legalized medical and recreational marijuana and with the high prevalence of prescription drug use in the United States, drugged driving has become a public health issue. In response, states have passed laws intended to decrease traffic accidents and deaths related to drugged driving.